vs
Side-by-side financial comparison of LCNB CORP (LCNB) and SBC Medical Group Holdings Inc (SBC). Click either name above to swap in a different company.
SBC Medical Group Holdings Inc is the larger business by last-quarter revenue ($39.6M vs $23.9M, roughly 1.7× LCNB CORP). SBC Medical Group Holdings Inc runs the higher net margin — 35.9% vs 23.7%, a 12.2% gap on every dollar of revenue. On growth, LCNB CORP posted the faster year-over-year revenue change (5.1% vs -10.9%). SBC Medical Group Holdings Inc produced more free cash flow last quarter ($51.2M vs $33.4M). Over the past eight quarters, LCNB CORP's revenue compounded faster (15.7% CAGR vs -15.0%).
LCNB Corp is a United States-based financial holding company that operates through its national bank subsidiary, providing a full suite of retail and commercial banking products and services including deposit accounts, various loan products, wealth management, and insurance solutions primarily to individual consumers, small and medium-sized enterprises and local community organizations across regional markets in Ohio.
SBC Medical Group Holdings Inc. is a leading Japan-headquartered healthcare provider primarily focused on aesthetic medicine, dermatology, and anti-aging wellness services. It operates an extensive network of clinics across Japan, catering to both domestic patients and international medical tourists, with core offerings including cosmetic surgery and non-invasive skincare treatments.
LCNB vs SBC — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $23.9M | $39.6M |
| Net Profit | $5.7M | $14.2M |
| Gross Margin | — | 73.1% |
| Operating Margin | 29.2% | 32.5% |
| Net Margin | 23.7% | 35.9% |
| Revenue YoY | 5.1% | -10.9% |
| Net Profit YoY | -7.6% | 117.2% |
| EPS (diluted) | $0.40 | $0.15 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $23.9M | $39.6M | ||
| Q3 25 | $23.8M | $43.4M | ||
| Q2 25 | $22.8M | $43.4M | ||
| Q1 25 | $21.5M | $47.3M | ||
| Q4 24 | $22.7M | $44.4M | ||
| Q3 24 | $21.4M | $53.1M | ||
| Q2 24 | $19.3M | $53.1M | ||
| Q1 24 | $17.8M | $54.8M |
| Q4 25 | $5.7M | $14.2M | ||
| Q3 25 | $6.9M | $12.8M | ||
| Q2 25 | $5.9M | $2.5M | ||
| Q1 25 | $4.6M | $21.5M | ||
| Q4 24 | $6.1M | $6.5M | ||
| Q3 24 | $4.5M | $2.8M | ||
| Q2 24 | $925.0K | $18.5M | ||
| Q1 24 | $1.9M | $18.8M |
| Q4 25 | — | 73.1% | ||
| Q3 25 | — | 70.6% | ||
| Q2 25 | — | 69.2% | ||
| Q1 25 | — | 79.7% | ||
| Q4 24 | — | 76.3% | ||
| Q3 24 | — | 81.5% | ||
| Q2 24 | — | 74.2% | ||
| Q1 24 | — | 72.1% |
| Q4 25 | 29.2% | 32.5% | ||
| Q3 25 | 35.6% | 36.6% | ||
| Q2 25 | 31.6% | 33.6% | ||
| Q1 25 | 25.6% | 51.1% | ||
| Q4 24 | 32.9% | 10.6% | ||
| Q3 24 | 24.9% | 26.1% | ||
| Q2 24 | 4.9% | 51.4% | ||
| Q1 24 | 12.5% | 44.6% |
| Q4 25 | 23.7% | 35.9% | ||
| Q3 25 | 29.1% | 29.6% | ||
| Q2 25 | 26.0% | 5.7% | ||
| Q1 25 | 21.4% | 45.4% | ||
| Q4 24 | 27.0% | 14.7% | ||
| Q3 24 | 21.2% | 5.3% | ||
| Q2 24 | 4.8% | 34.8% | ||
| Q1 24 | 10.7% | 34.2% |
| Q4 25 | $0.40 | $0.15 | ||
| Q3 25 | $0.49 | $0.12 | ||
| Q2 25 | $0.41 | $0.02 | ||
| Q1 25 | $0.33 | $0.21 | ||
| Q4 24 | $0.44 | $0.05 | ||
| Q3 24 | $0.31 | $0.03 | ||
| Q2 24 | $0.07 | $0.20 | ||
| Q1 24 | $0.15 | $0.20 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $21.6M | $164.1M |
| Total DebtLower is stronger | $104.4M | $42.8M |
| Stockholders' EquityBook value | $273.9M | $248.3M |
| Total Assets | $2.2B | $380.4M |
| Debt / EquityLower = less leverage | 0.38× | 0.17× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $21.6M | $164.1M | ||
| Q3 25 | $35.9M | $127.4M | ||
| Q2 25 | $49.8M | $152.7M | ||
| Q1 25 | $37.7M | $132.1M | ||
| Q4 24 | $35.7M | $125.0M | ||
| Q3 24 | $39.4M | $137.4M | ||
| Q2 24 | $34.9M | — | ||
| Q1 24 | $33.0M | — |
| Q4 25 | $104.4M | $42.8M | ||
| Q3 25 | $104.7M | $21.1M | ||
| Q2 25 | $105.0M | $7.1M | ||
| Q1 25 | $104.6M | $6.9M | ||
| Q4 24 | $155.2M | $6.6M | ||
| Q3 24 | $155.7M | $823.2K | ||
| Q2 24 | $162.2M | — | ||
| Q1 24 | $162.6M | — |
| Q4 25 | $273.9M | $248.3M | ||
| Q3 25 | $269.9M | $248.0M | ||
| Q2 25 | $263.5M | $244.6M | ||
| Q1 25 | $258.7M | $226.4M | ||
| Q4 24 | $253.0M | $195.1M | ||
| Q3 24 | $253.2M | $205.0M | ||
| Q2 24 | $245.2M | $8.8M | ||
| Q1 24 | $233.7M | $9.0M |
| Q4 25 | $2.2B | $380.4M | ||
| Q3 25 | $2.2B | $321.4M | ||
| Q2 25 | $2.3B | $315.3M | ||
| Q1 25 | $2.3B | $284.6M | ||
| Q4 24 | $2.3B | $266.1M | ||
| Q3 24 | $2.3B | $296.5M | ||
| Q2 24 | $2.4B | $19.5M | ||
| Q1 24 | $2.3B | $19.8M |
| Q4 25 | 0.38× | 0.17× | ||
| Q3 25 | 0.39× | 0.09× | ||
| Q2 25 | 0.40× | 0.03× | ||
| Q1 25 | 0.40× | 0.03× | ||
| Q4 24 | 0.61× | 0.03× | ||
| Q3 24 | 0.61× | 0.00× | ||
| Q2 24 | 0.66× | — | ||
| Q1 24 | 0.70× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $34.4M | $52.0M |
| Free Cash FlowOCF − Capex | $33.4M | $51.2M |
| FCF MarginFCF / Revenue | 140.2% | 129.3% |
| Capex IntensityCapex / Revenue | 4.0% | 2.0% |
| Cash ConversionOCF / Net Profit | 6.08× | 3.66× |
| TTM Free Cash FlowTrailing 4 quarters | $54.5M | $23.3M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $34.4M | $52.0M | ||
| Q3 25 | $14.0M | $-20.9M | ||
| Q2 25 | $5.5M | $-8.3M | ||
| Q1 25 | $2.2M | $1.9M | ||
| Q4 24 | $93.2M | $-7.3M | ||
| Q3 24 | $11.9M | $5.0M | ||
| Q2 24 | $54.9M | $19.2M | ||
| Q1 24 | $-11.9M | $3.7M |
| Q4 25 | $33.4M | $51.2M | ||
| Q3 25 | $13.7M | $-20.9M | ||
| Q2 25 | $5.2M | $-8.6M | ||
| Q1 25 | $2.1M | $1.7M | ||
| Q4 24 | $89.4M | $-7.9M | ||
| Q3 24 | $10.5M | $4.6M | ||
| Q2 24 | $53.8M | $18.3M | ||
| Q1 24 | $-12.8M | $3.0M |
| Q4 25 | 140.2% | 129.3% | ||
| Q3 25 | 57.4% | -48.3% | ||
| Q2 25 | 23.0% | -19.9% | ||
| Q1 25 | 10.0% | 3.5% | ||
| Q4 24 | 394.0% | -17.8% | ||
| Q3 24 | 49.0% | 8.7% | ||
| Q2 24 | 278.6% | 34.5% | ||
| Q1 24 | -71.8% | 5.4% |
| Q4 25 | 4.0% | 2.0% | ||
| Q3 25 | 1.3% | 0.1% | ||
| Q2 25 | 1.0% | 0.7% | ||
| Q1 25 | 0.3% | 0.5% | ||
| Q4 24 | 16.7% | 1.3% | ||
| Q3 24 | 6.7% | 0.8% | ||
| Q2 24 | 5.9% | 1.6% | ||
| Q1 24 | 4.8% | 1.3% |
| Q4 25 | 6.08× | 3.66× | ||
| Q3 25 | 2.02× | -1.63× | ||
| Q2 25 | 0.92× | -3.39× | ||
| Q1 25 | 0.48× | 0.09× | ||
| Q4 24 | 15.23× | -1.12× | ||
| Q3 24 | 2.63× | 1.77× | ||
| Q2 24 | 59.35× | 1.04× | ||
| Q1 24 | -6.24× | 0.20× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
LCNB
Segment breakdown not available.
SBC
| Franchising | $10.3M | 26% |
| Medical Corporation Shobikai | $8.1M | 21% |
| Medical Corporation Nasukai | $7.2M | 18% |
| Management Services | $6.3M | 16% |
| Rental Services | $4.3M | 11% |
| Medical Corporation Association Furinkai | $3.0M | 8% |
| Japan Medical And Beauty Inc | $656.5K | 2% |
